INMB Insider Trading Activity and SEC Form 4 Filings
INMB insider trading summary
No open-market insider purchases or sales of Inmune Bio, Inc. (INMB) have been reported on SEC Form 4 in the past 12 months.
Latest INMB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 30, 2024 | David J Moss | Chief Financial Officer | Buy | $53K (10,000 @ $5.29) |
| Sep 12, 2024 | David J Moss | Chief Financial Officer | Buy | $49K (7,690 @ $6.38) |
| Sep 12, 2024 | Raymond Joseph Tesi | President and CEO | Buy | $98K (15,380 @ $6.38) |
| Jun 25, 2024 | Scott Juda | Director | Buy | $36K (5,000 @ $7.27) |
| Nov 10, 2023 | Scott Juda | Director | Buy | $49K (7,000 @ $6.95) |
| Jul 12, 2023 | Timothy j Schroeder | Director | Sell | $110K (10,000 @ $11.01) |
| Mar 17, 2023 | David J Moss | CFO, Treasurer & Secretary | Buy | $16K (2,500 @ $6.42) |
| May 27, 2022 | David J Moss | CFO, Treasurer & Secretary | Buy | $20K (3,000 @ $6.79) |
| May 26, 2022 | Raymond Joseph Tesi | President and CEO | Buy | $40K (6,300 @ $6.41) |
| May 26, 2022 | David J Moss | CFO, Treasurer & Secretary | Buy | $48K (7,700 @ $6.27) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.